The people behind Kyberlife.
Operators and executives who have built and led some of the world's largest healthcare, technology and finance businesses.
Board of Directors
Michael Tillmann has over 25 years of experience in senior executive and supervisory board roles, including President & CEO for Roche Diagnostics in North America and before that in the Asia Pacific and Europe. Mr Tillmann also founded a PCR company, Vela Diagnostics, with the vision of establishing the company as a global provider of integrated diagnostics solutions that address individual customer needs in molecular diagnostics focused on PCR and NGS. Prior to the Roche assignments, Mr Tillmann was Managing Director of the start-up company Artus GmbH, which was later acquired by Qiagen. Mr Tillmann started his career in a pharmaceutical trading house, Holstein GmbH, as Managing Director, representing over 20 principals in Japan and South East Asia.
Mr. Tillmann is also an active entrepreneur, supporting companies as an investor and advisor. He supports companies in their strategic positioning, including fund raising and M&A activities, raising in his career close to $500 million in funding and accompanying multiple company exits from trade sales to listings.
Ryan James Lim is a seasoned entrepreneur despite his young age, having started his first company at 19. Prior to Kyberlife, Mr Lim ran an e-commerce marketplace start-up for B2C users in the cosmetics industry whose technology was absorbed into Kyberlife. Mr Lim is trained in Chemistry, Biomedical & Pharmaceutical science; with a history in the healthcare industry, working as a research and surgical assistant in 6 different hospitals across 3 different countries.
At the age of 16, he was thrown into the pharmaceutical corporate world, and also served as a research staff at the Metabolomics Facility of Duke-NUS Medical School where he worked on analyzing metabolites in individual samples from experimental organisms or in patients and studying both experimental animal models of metabolic diseases.
Prior to Duke-NUS, Mr Lim served as a surgical resident in Shanghai Renji Hospital and was a prominent photography producer in Singapore that was invited to be featured for Today at Apple and other publications. He is also a passionate volunteer for The Giving Tree and The Origami Project in collaboration with St. Luke's Eldercare.
Dieter Schlosser career began in 1982 at Daimler Benz AG, where he held a key position as General Manager for IT in Asia, followed by other key positions at DKSH and BHP. Later, as CEO of SoftwareOne, he became one of the key figures in the global technology industry. During his tenure there, he was responsible for key milestones such as the acquisition of Comparex, the successful IPO of SoftwareOne in October 2019 and the transformation of the company into a global provider of software and cloud solutions, leading to a doubling of net sales to over one billion Swiss francs by 2022. He is a Global Transformation leader, Chief Information Officer, and Chief Operating Officer with a proven track record of achievements spanning 30 years throughout Asia Pacific, Middle East, Europe and Africa. Dieter has managed multi-cultural teams comprising up to 1300 professionals across multiple locations along with annual budgets of over $750M USD. He is effective in both implementing greenfield approaches as well as executing complex turnarounds.
Since 2012 Dieter is the Global COO & Transformation Leader of the world's largest SW Portfolio Management company headquartered in Switzerland with over $5.5B USD in 2015 revenue and 40% year-over-year growth. As a unique industry player focused on the end-to-end management of an organization's software portfolio, the company's portfolio ranges from software compliance management and risk mitigation services to technology roadmapping geared towards enterprise-wide cloud deployment.
Joanna Ling has a background in Landscape Architecture and an Executive MBA from Oxford University. She volunteers as a mentor for Oxford University Innovation (OUI). She is currently a member of YPO (Young Presidents Organization) and has also been a member of EO (Entrepreneur's Organization) for 14 years, serving on various boards for EO on a global scale. She founded the EO APAC Bridge Chapter and served as its founding president for 2 terms.
As the CEO of PE Holdings, Joanna Ling helms a real estate conglomerate that focuses on retail, commercial and residential developments all over Malaysia. Under her leadership, PE Holdings has successfully launched and operated large scale projects including flagship malls in Kuching and Bintulu, and the largest outlet mall in Southeast Asia located in Penang, Malaysia. They have successfully navigated the pandemic to transition into residential developments with a 496-unit condominium in Penang. On the development front, Joanna currently focussed on a 33-storey office development, 5 acres medical and healthcare centric development and a 60-acre housing development.
She believes the next frontier of real estate is age-tech and smart sustainable living and continues to explore innovations to improve quality of life. Joanna also oversees a diverse range of subsidiaries including bore pile engineering, insurance, road building, waste management and food & beverage, demonstrating her proficiency in managing multi-faceted organizations.
Bern Lepper, with over 25 years of professional sales, marketing, logistics and general management experience, Mr. Lepper is the Founder and CEO of Intega Health. Prior to Intega, he held multiple senior executive positions in DKSH (DiethelmKellerSiberHegner) with the last role held as the Regional Vice President of Healthcare.
He was responsible for leading the Healthcare organizations in SEA to Implement Market Expansion Services and attracting >200 Healthcare companies as new business partners for Market Entry; with coverage of the Pharmaceutical, OTC/Consumer Health, Medical Devices & Supplies, Dental, Ophthalmology and Companion Animal Health segments. Mr Lepper also has a track record in emerging pharmaceutical markets in Russia and SEA where he was the Managing Director of Sanofi-Aventis Indonesia, CFO of Aventis Pharma Thailand and Area Manager of the Eastern Europe Pharma Division of Hoechst AG.
Mr Henrichwark leads SPRIM Ventures initiatives in Medtech. Sven has 20 years of operational leadership experience in the biotech, life science and medical technology industries with a successful track record as COO, CMO and GM of businesses at $1B/>1000FTE level and as a CEO at the $50-100M level. With over 10 years experience working in the US, Europe and Asia respectively, Sven has a global perspective and is passionate about bringing people and ideas together to build great businesses and teams.
Prior to SPRIM, he served as the executive vice president of APAC for AVANTOR/VWR, one of the largest laboratory product distributors internationally. Prior to joining VWR, Sven was the CEO of Echosens, Global Commercial GM of GE Life Sciences Bioprocess, Service GM and COO of GE Healthcare in Asia Pacific and the CMO of GE Life Sciences. In the earlier part of his career, Sven worked for the Monitor Group in LA and Paris and as a product manager for Incyte Genomics in the Bay Area.
Advisory Board & Operating Members
Natalie Liem, PhD, serves as a Managing Director and esteemed member of our Advisory Board, bringing extensive expertise in medical devices. Dr. Liem holds a Bachelor of Science in Genetics and Microbiology, a Master of Science in Prenatal Genetics and Fetal Medicine, and a PhD in Childhood Leukemia from the School of Paediatrics. Her deep understanding of both the clinical and scientific aspects of medicine, coupled with her leadership experience, provides invaluable strategic guidance to our organization.
Dr. Michael Gorriz served as Global Group Chief Information Officer of Standard Chartered Bank, where he was responsible for the banking operations, systems development and technology infrastructure which underpin the Bank's client services. He was also instrumental in defining and implementing the Standard Chartered Bank's digital and innovation agendas. An industry award winner, Michael joined from Daimler AG (Mercedes-Benz) which he served as CIO, with responsibility for the smooth operation of all Daimler systems and the management of IT projects globally. He held various CIO roles within the Daimler group.
Romi has extensive international experience in large European MNC country & HQ functions in Asia, Australia & Europe. Excellent track record in management of Global business units within established complex matrix organization structures, and as Global CFO in tech start ups, over the last 7 years in Investor funded ventures, focused on hands on fund raising, M&A, resource management, building up of organization structures, systems and processes to sustainable operations.
Romi has Cross Industry business competency with comprehensive experience in hi-tech Electrical equipment, Industrial automation, Information technology, and Life Sciences industries.
He has Strong General Management and Core Finance skills backed with hands on Business and Financial Expertise in Business Strategy, Budgeting, Forecasting, Controlling, Reporting, Risk Management and Governance, under both IFRS and US GAAP environments.
Global tech executive with 13+ years of experience scaling high-growth technology businesses, including some of APAC’s leading marketplaces and global AI-era infrastructure. Experience spans early-stage VC-backed disruptors, global public companies, and frontier technology, with leadership across operations, commercial, partnerships, market strategy, public policy, and cross-functional execution.
Dr Lim is currently the CEO of a microbiome company, AMiLi, and advises senior officials at public sector agencies. He has extensive experience consulting and advising multinational private and NGO clients on national and regional strategies for go-to-market plans and implementation, government engagement, and public-private partnerships. Dr. Jeremy holds appointments at (Saw Swee Hock School of Public Health, and Duke-NUS medical school).
Dr Jeremy also served as a partner in Oliver Wyman's Health and Life-Science practice and was the CEO of Fortis Colorectal Hospital. He has worked in senior executive roles in both public and private sectors, including time spent as a senior official in the Ministry of Health where he was also involved in a number of 'Whole of Government' initiatives. Dr. Jeremy chairs the steering committee of NIHA (NUS Initiative to Improve Health in Asia), and sits on the Behavioral Sciences Institute SMU, Centre for Health Informatics (NUS), and Next Age Institute (NUS) advisory boards.
He also contributes as immediate past President of the Fulbright Association and convener for the Johns Hopkins Bloomberg School of Public Health Singapore alumni. Dr. Jeremy enjoys serving in the NGO sector, the medical advisory committee of Dover Park Hospice, and regionally is a Member of the 'Save the Children' Asia Corporate Advisory Council. He is also a volunteer physician with HealthServe.
As the former Global CEO of Boehringer Ingelheim, a position he held until 1994, he provided visionary leadership that culminated in the strategic acquisition of Boehringer Ingelheim's ber division by Roche, a significant milestone in the company's history.
Ready to transform your procurement?
Join 2,000+ institutional customers and 150+ organizations already saving time, cost and effort with Kyberlife.